Lymphoma, large-cell

Common Name(s)

Lymphoma, large-cell

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Lymphoma, large-cell" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Lymphoma, large-cell" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Lymphoma, large-cell" returned 0 free, full-text research articles on human participants.

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Lymphoma, large-cell" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
 

Status: Not yet recruiting

Condition Summary: Anaplastic Large Cell Lymphoma, ALK-Positive; Systemic Anaplastic Large Cell Lymphoma

 

Last Updated: 13 Oct 2017

Go to URL
Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
 

Status: Recruiting

Condition Summary: Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Neuroblastoma; Unspecified Childhood Solid Tumor, Protocol Specific

 

Last Updated: 10 May 2017

Go to URL
Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL
 

Status: Recruiting

Condition Summary: ALK+ Anaplastic Large Cell Lymphoma

 

Last Updated: 26 Jun 2017

Go to URL